Company intelligence / Profile preview

Rokland

Limerick, Pennsylvania, USA

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Rockland Immunochemicals is a leading global manufacturer of antibodies and reagents for life science research, diagnostics, and drug discovery. Founded in 1962, the company provides a comprehensive portfolio of primary and secondary antibodies, proteins, peptides, and assay kits, with a focus on high-quality manufacturing and rigorous validation. Rockland also offers specialized custom services, including antibody development, assay optimization, and large-scale manufacturing under GMP-like conditions. Their products support research across various therapeutic areas, including oncology, immunology, and infectious diseases, serving academic, clinical, and industrial laboratories worldwide.

Modalities: AntibodyProteinPeptidesRecombinant protein
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Rokland.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rokland.

Explore the full profile